Sword Health, an AI-powered digital health startup, has raised $40 million at a $4 billion valuation, a 33% jump from the $3 billion price tag it earned just a year ago. The funding was led by returning investor, General Catalyst.
Even though 10-year-old Sword Health is cash-flow positive, its CEO and founder, Virgílio Bento, told TechCrunch that he opted to raise additional capital for two key reasons: to update the company’s valuation, and have funds readily available for strategic acquisitions.
Sword Health, which began as a virtual physical therapist and has since expanded into offering pelvic health and mental health services, had previously considered a near-term IPO. Bento told TechCrunch last year that a 2025 listing was a possibility.
Despite the recent successful IPOs of counterparts Hinge Health and Omada, and Sword’s healthy $240 million annual revenue run rate, Bento is reconsidering his IPO plans.
“It’s going to be much later than everyone expects,” he said.
Bento’s goal is for Phoenix, Sword’s AI care specialist, to extend remote healthcare beyond musculoskeletal pain and pelvic floor care to numerous conditions, such as cardiovascular care, gastroenterological health, and speech therapy.
“I want to IPO when I have lots of different proof points at scale in many different care verticals — so maybe 2028,” he said.
Techcrunch event Save $200+ on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Save $200+ on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Boston, MA | REGISTER NOW
In recent months, Bento has embarked on what he calls an “educational journey” to learn about managing a public company, speaking with CEOs of various public companies and bankers.
“At the end of that education period, I realized that if you ask me why we shouldn’t IPO, I can give you 10 reasons. If you ask me why we should IPO, I cannot find one reason,” he said.
... continue reading